Transarterial Chemoembolization (TACE)

TACE is a minimally invasive, non-surgical procedure used to treat Malignant Lesions in the Liver (Liver Cancer) that cannot be treated with surgery. The procedure is done with a catheter to deliver both Chemotherapy Medication and embolization materials into the blood vessels that lead to the Tumour.

It works by blocking the blood supply to Tumour. Once the blood supply is blocked (Embolized) the Chemotherapy works better on the Tumour.

TACE can be helpful for:

• Patients having unresectable HCC or Liver Transplant candidates with suspected HCC
• Patients with Single or Multiple Hepatocellular Carcinoma (HCC), can undergo TACE
• For patients with extensive Tumour Bulk, Multi-nodular Spread or Impaired Liver Function, TACE can be considered

Advantages of TACE:

• Treat malignant lesions in the Liver
• Optimizes the ability to shrink or eradicate Tumours by targeting them precisely and blocking their blood flow
• TACE can help in preventing Tumour growth
• It helps keep the Liver working well and therefore the patients continue a good quality of life
• If the patient is waiting for a Liver Transplant, TACE can also be used as a bridge to try to control Cancer while the patient is waiting for new a Liver

This treatment option is currently performed by a few doctors only. We are proud to announce that we have Dr M C Uthappa - Director of Interventional Radiology and Interventional Oncology, with us. Dr Uthappa has experience with over 13500 major Interventional Radiology cases. He is an expert in all types of Interventional Radiology procedures for Liver Cancer including TARE, Percutaneous Ethanol Injection(PEI), RFA, TACE, DC Bead Embolisation, Portal Vein Embolisation and Radio Embolisation (SIRT).